Drug Profile
Research programme: depressive disorder and dysuria therapeutics - Alvogen Korea
Alternative Names: KW 21072; KW 21097Latest Information Update: 28 Jul 2019
Price :
$50
*
At a glance
- Originator KunWha Pharmaceutical
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Depressive disorders; Dysuria
Most Recent Events
- 28 Jul 2019 No recent reports of development identified for research development in Depressive disorders in South Korea (PO)
- 28 Jul 2019 No recent reports of development identified for research development in Dysuria in South Korea (PO)
- 01 Jun 2015 Early research in Depressive disorders in South Korea (PO) before June 2015